Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 29 | 2023 | 739 | 3.270 |
Why?
|
| Intensive Care Units, Pediatric | 24 | 2024 | 477 | 2.950 |
Why?
|
| Nutritional Support | 9 | 2023 | 79 | 2.500 |
Why?
|
| Dietary Proteins | 11 | 2017 | 255 | 2.100 |
Why?
|
| Malnutrition | 6 | 2023 | 224 | 1.750 |
Why?
|
| Nutritional Requirements | 11 | 2017 | 185 | 1.350 |
Why?
|
| Lung Transplantation | 5 | 2022 | 383 | 1.310 |
Why?
|
| Energy Intake | 9 | 2023 | 521 | 1.080 |
Why?
|
| Nutritional Status | 10 | 2023 | 353 | 1.010 |
Why?
|
| Cystic Fibrosis | 3 | 2022 | 294 | 0.870 |
Why?
|
| Energy Metabolism | 9 | 2013 | 997 | 0.770 |
Why?
|
| Respiration, Artificial | 9 | 2023 | 585 | 0.760 |
Why?
|
| Body Composition | 2 | 2015 | 606 | 0.740 |
Why?
|
| Child | 49 | 2024 | 30559 | 0.700 |
Why?
|
| Child Nutrition Disorders | 4 | 2017 | 77 | 0.690 |
Why?
|
| Parenteral Nutrition | 7 | 2019 | 213 | 0.690 |
Why?
|
| Enteral Nutrition | 6 | 2022 | 347 | 0.670 |
Why?
|
| Nutrition Policy | 3 | 2016 | 109 | 0.630 |
Why?
|
| Calorimetry, Indirect | 4 | 2011 | 57 | 0.630 |
Why?
|
| Multiple Organ Failure | 4 | 2023 | 177 | 0.620 |
Why?
|
| Lung Diseases | 1 | 2023 | 755 | 0.590 |
Why?
|
| Infant | 30 | 2024 | 13999 | 0.560 |
Why?
|
| Liver Transplantation | 5 | 2024 | 1195 | 0.560 |
Why?
|
| Nutrition Assessment | 6 | 2017 | 176 | 0.560 |
Why?
|
| Heart Defects, Congenital | 4 | 2023 | 1795 | 0.530 |
Why?
|
| Length of Stay | 12 | 2024 | 2007 | 0.500 |
Why?
|
| Critical Care | 7 | 2021 | 796 | 0.500 |
Why?
|
| Biliary Atresia | 3 | 2024 | 201 | 0.500 |
Why?
|
| Child, Preschool | 31 | 2024 | 17061 | 0.490 |
Why?
|
| Acute Kidney Injury | 3 | 2021 | 761 | 0.490 |
Why?
|
| Failure to Thrive | 1 | 2014 | 96 | 0.470 |
Why?
|
| Insulin | 4 | 2011 | 1483 | 0.450 |
Why?
|
| Child Development | 1 | 2015 | 266 | 0.420 |
Why?
|
| Growth Disorders | 1 | 2014 | 223 | 0.420 |
Why?
|
| Chronic Disease | 3 | 2014 | 1824 | 0.420 |
Why?
|
| Glucose | 3 | 2011 | 1218 | 0.390 |
Why?
|
| Airway Extubation | 2 | 2024 | 73 | 0.390 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 120 | 0.370 |
Why?
|
| Thinness | 1 | 2011 | 79 | 0.370 |
Why?
|
| Nitrogen | 2 | 2001 | 181 | 0.340 |
Why?
|
| Adolescent | 27 | 2024 | 32767 | 0.330 |
Why?
|
| Galactose | 1 | 2009 | 79 | 0.330 |
Why?
|
| Carbon Isotopes | 2 | 2009 | 363 | 0.320 |
Why?
|
| Fructose | 1 | 2009 | 67 | 0.320 |
Why?
|
| Patient Admission | 2 | 2019 | 231 | 0.300 |
Why?
|
| Eating | 3 | 2023 | 448 | 0.300 |
Why?
|
| Overweight | 1 | 2011 | 484 | 0.300 |
Why?
|
| Humans | 61 | 2024 | 270740 | 0.290 |
Why?
|
| Triage | 2 | 2019 | 255 | 0.290 |
Why?
|
| Retrospective Studies | 24 | 2024 | 39890 | 0.290 |
Why?
|
| Amino Acids | 5 | 2021 | 783 | 0.280 |
Why?
|
| Body Weight | 3 | 2017 | 1307 | 0.270 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 552 | 0.260 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2015 | 160 | 0.250 |
Why?
|
| Risk Factors | 9 | 2024 | 17888 | 0.250 |
Why?
|
| Homeostasis | 2 | 2011 | 925 | 0.250 |
Why?
|
| Basal Metabolism | 4 | 2016 | 86 | 0.240 |
Why?
|
| Male | 38 | 2024 | 128315 | 0.230 |
Why?
|
| Patient Discharge | 2 | 2019 | 698 | 0.230 |
Why?
|
| Vitamins | 2 | 2023 | 149 | 0.230 |
Why?
|
| Sepsis | 5 | 2011 | 686 | 0.230 |
Why?
|
| Blood Glucose | 5 | 2011 | 1269 | 0.230 |
Why?
|
| Respiratory Dead Space | 1 | 2003 | 4 | 0.220 |
Why?
|
| Carbohydrates | 1 | 2023 | 55 | 0.220 |
Why?
|
| Micronutrients | 1 | 2023 | 74 | 0.220 |
Why?
|
| Acute-On-Chronic Liver Failure | 1 | 2024 | 62 | 0.210 |
Why?
|
| Female | 38 | 2024 | 148940 | 0.210 |
Why?
|
| Latin America | 2 | 2023 | 127 | 0.210 |
Why?
|
| Organ Dysfunction Scores | 1 | 2022 | 69 | 0.210 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2003 | 88 | 0.210 |
Why?
|
| Hypernatremia | 1 | 2023 | 30 | 0.210 |
Why?
|
| Intensive Care Units | 5 | 2022 | 738 | 0.210 |
Why?
|
| Protein-Energy Malnutrition | 2 | 2013 | 78 | 0.200 |
Why?
|
| Status Asthmaticus | 1 | 2021 | 23 | 0.200 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2023 | 98 | 0.190 |
Why?
|
| Hyponatremia | 1 | 2023 | 87 | 0.190 |
Why?
|
| Hemodiafiltration | 1 | 2021 | 19 | 0.190 |
Why?
|
| Liver Cirrhosis | 4 | 2024 | 1046 | 0.190 |
Why?
|
| Dietary Carbohydrates | 1 | 2001 | 127 | 0.180 |
Why?
|
| Pediatrics | 2 | 2021 | 1186 | 0.180 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 38 | 0.180 |
Why?
|
| Dietary Fats | 1 | 2001 | 341 | 0.170 |
Why?
|
| Perioperative Care | 2 | 2021 | 447 | 0.170 |
Why?
|
| End Stage Liver Disease | 1 | 2021 | 189 | 0.160 |
Why?
|
| Nutritionists | 1 | 2019 | 8 | 0.160 |
Why?
|
| Spain | 1 | 2019 | 100 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2021 | 255 | 0.160 |
Why?
|
| Societies, Medical | 2 | 2017 | 1320 | 0.150 |
Why?
|
| Child Nutritional Physiological Phenomena | 3 | 2017 | 176 | 0.150 |
Why?
|
| Hospitals, High-Volume | 1 | 2019 | 76 | 0.150 |
Why?
|
| Oxygen Consumption | 2 | 2008 | 418 | 0.150 |
Why?
|
| Ventilators, Mechanical | 1 | 2018 | 47 | 0.150 |
Why?
|
| Hemoptysis | 1 | 1997 | 41 | 0.150 |
Why?
|
| Parenteral Nutrition, Total | 3 | 2011 | 139 | 0.140 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 1997 | 19 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2021 | 510 | 0.140 |
Why?
|
| Patient Care Team | 2 | 2019 | 823 | 0.140 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2017 | 103 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 2400 | 0.140 |
Why?
|
| Postoperative Care | 1 | 2020 | 728 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 1999 | 212 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2024 | 5681 | 0.130 |
Why?
|
| Acute Disease | 3 | 2013 | 2493 | 0.130 |
Why?
|
| Staphylococcus aureus | 2 | 2012 | 562 | 0.120 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2015 | 50 | 0.120 |
Why?
|
| Electric Impedance | 1 | 2015 | 101 | 0.120 |
Why?
|
| Brain Edema | 1 | 2015 | 95 | 0.120 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 466 | 0.120 |
Why?
|
| Growth | 1 | 2014 | 125 | 0.120 |
Why?
|
| Hospital Mortality | 3 | 2018 | 1234 | 0.120 |
Why?
|
| Body Height | 1 | 2015 | 234 | 0.120 |
Why?
|
| Infant, Newborn | 7 | 2023 | 8699 | 0.110 |
Why?
|
| Fluid Therapy | 1 | 2015 | 192 | 0.110 |
Why?
|
| Staphylococcal Infections | 2 | 2012 | 678 | 0.110 |
Why?
|
| Asthma | 1 | 2021 | 895 | 0.110 |
Why?
|
| Vital Capacity | 1 | 2013 | 140 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 344 | 0.100 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 327 | 0.100 |
Why?
|
| Logistic Models | 2 | 2016 | 3444 | 0.100 |
Why?
|
| Blood Coagulation Disorders | 1 | 2012 | 115 | 0.100 |
Why?
|
| Hospitals, Pediatric | 4 | 2018 | 799 | 0.090 |
Why?
|
| Hospital Costs | 2 | 2024 | 244 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2011 | 111 | 0.090 |
Why?
|
| Coinfection | 1 | 2012 | 200 | 0.090 |
Why?
|
| Nutrition Disorders | 1 | 2010 | 51 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 214 | 0.090 |
Why?
|
| Vitamin D | 1 | 2013 | 260 | 0.090 |
Why?
|
| Chemoreceptor Cells | 1 | 2009 | 17 | 0.080 |
Why?
|
| Albumins | 1 | 2011 | 262 | 0.080 |
Why?
|
| Health Status | 1 | 2013 | 631 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 247 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2011 | 732 | 0.080 |
Why?
|
| Trace Elements | 1 | 2009 | 35 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2013 | 715 | 0.080 |
Why?
|
| Metabolic Clearance Rate | 1 | 2009 | 242 | 0.080 |
Why?
|
| Sample Size | 1 | 2009 | 213 | 0.080 |
Why?
|
| Metals | 1 | 2009 | 148 | 0.080 |
Why?
|
| Sodium Bicarbonate | 1 | 2008 | 56 | 0.080 |
Why?
|
| Delphi Technique | 2 | 2019 | 275 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2013 | 2232 | 0.080 |
Why?
|
| Kidney | 1 | 2016 | 2121 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2009 | 310 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2009 | 729 | 0.070 |
Why?
|
| Incidence | 4 | 2021 | 5824 | 0.070 |
Why?
|
| Renal Replacement Therapy | 1 | 2009 | 151 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 599 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2009 | 337 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 517 | 0.070 |
Why?
|
| Young Adult | 4 | 2020 | 22251 | 0.070 |
Why?
|
| Folic Acid | 1 | 2009 | 369 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 310 | 0.070 |
Why?
|
| Texas | 6 | 2020 | 6449 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2012 | 765 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 904 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2009 | 1608 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1158 | 0.060 |
Why?
|
| Calorimetry | 1 | 2003 | 64 | 0.060 |
Why?
|
| Adult | 6 | 2021 | 82040 | 0.050 |
Why?
|
| Severity of Illness Index | 6 | 2013 | 4372 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2024 | 131 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 341 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 323 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 4960 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2022 | 13414 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 266 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2001 | 581 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 317 | 0.040 |
Why?
|
| Age Factors | 3 | 2013 | 5457 | 0.040 |
Why?
|
| Prognosis | 3 | 2024 | 22505 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2011 | 453 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2021 | 33737 | 0.040 |
Why?
|
| Family | 1 | 2024 | 783 | 0.040 |
Why?
|
| Renal Dialysis | 2 | 2021 | 917 | 0.040 |
Why?
|
| Inservice Training | 1 | 2019 | 74 | 0.040 |
Why?
|
| Erythema Multiforme | 1 | 1998 | 13 | 0.040 |
Why?
|
| Cold Ischemia | 1 | 2018 | 23 | 0.040 |
Why?
|
| Rest | 1 | 1998 | 69 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2019 | 196 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1998 | 74 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2019 | 138 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 5923 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2018 | 221 | 0.040 |
Why?
|
| Prevalence | 2 | 2018 | 3404 | 0.040 |
Why?
|
| Operative Time | 1 | 2018 | 255 | 0.040 |
Why?
|
| Amino Acids, Essential | 1 | 2017 | 26 | 0.040 |
Why?
|
| Survival Rate | 2 | 2024 | 12541 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2024 | 914 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 391 | 0.030 |
Why?
|
| Resource Allocation | 1 | 1996 | 60 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1997 | 2315 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2019 | 9470 | 0.030 |
Why?
|
| Medical Futility | 1 | 1996 | 57 | 0.030 |
Why?
|
| Regression Analysis | 1 | 1999 | 1571 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1996 | 87 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 1998 | 483 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2015 | 42 | 0.030 |
Why?
|
| Health Resources | 1 | 1996 | 171 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 2015 | 159 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 497 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 1248 | 0.030 |
Why?
|
| Fever | 1 | 1997 | 521 | 0.030 |
Why?
|
| Quality Control | 1 | 2015 | 461 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2018 | 847 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 1997 | 581 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 727 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 984 | 0.030 |
Why?
|
| Familial Hypophosphatemic Rickets | 1 | 2013 | 8 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 2013 | 38 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 1997 | 408 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1228 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 90 | 0.030 |
Why?
|
| Bone Development | 1 | 2013 | 82 | 0.030 |
Why?
|
| Hypocalcemia | 1 | 2013 | 59 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 1996 | 318 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2021 | 9292 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 13006 | 0.030 |
Why?
|
| Consensus | 1 | 2017 | 1106 | 0.030 |
Why?
|
| Pneumonia | 1 | 1998 | 796 | 0.030 |
Why?
|
| Medical Audit | 1 | 2012 | 195 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2015 | 6764 | 0.020 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2013 | 81 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 4492 | 0.020 |
Why?
|
| Lipolysis | 1 | 2011 | 102 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2011 | 218 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 417 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2011 | 86 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 15218 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 375 | 0.020 |
Why?
|
| Leucine | 1 | 2011 | 380 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 2650 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 1437 | 0.020 |
Why?
|
| Premature Birth | 1 | 2013 | 408 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 2250 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 6224 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 1996 | 1302 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2008 | 328 | 0.020 |
Why?
|
| HIV Infections | 1 | 1998 | 2154 | 0.020 |
Why?
|
| Neoplasms | 1 | 2011 | 15927 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 848 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2005 | 180 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2005 | 141 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 147 | 0.010 |
Why?
|
| Virulence | 1 | 2005 | 352 | 0.010 |
Why?
|
| Proteins | 1 | 2011 | 2043 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 822 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2005 | 286 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2005 | 1076 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 5162 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 8130 | 0.010 |
Why?
|
| Bacteremia | 1 | 2005 | 721 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 3476 | 0.010 |
Why?
|
| United States | 1 | 2015 | 15861 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 6177 | 0.010 |
Why?
|
| Cost Control | 1 | 1996 | 45 | 0.010 |
Why?
|
| Life Support Care | 1 | 1996 | 52 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 3187 | 0.010 |
Why?
|